François Venter

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

François Venter, Michelle Moorhouse, Simiso Sokhela et al. · New England Journal of Medicine · 2019 · 684 citations · Full text

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial

François Venter, Simiso Sokhela, Bryony Simmons et al. · The Lancet HIV · 2020 · 249 citations

Week 96, Treatment And Prevention, Antiviral Drug Development +9

Long-COVID: An evolving problem with an extensive impact

Marc Mendelson, Jeremy Nel, Lucille Blumberg et al. · South African Medical Journal · 2020 · 246 citations · Full text

Characteristics and Outcomes of Adult Patients Lost to Follow-Up at an Antiretroviral Treatment Clinic in Johannesburg, South Africa

Rishikesh Dalal, Catherine MacPhail, Mmabatho Mqhayi et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2008 · 194 citations

Adult antiretroviral therapy guidelines 2017

Graeme Meintjes, Michelle Moorhouse, Sergio Carmona et al. · Southern African Journal of HIV Medicine · 2017 · 190 citations · Full text

Southern African Journal, Antiretroviral Therapy, Preventive Medicine +13